Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Dow
Moodys
Harvard Business School
McKesson

Last Updated: November 18, 2019

DrugPatentWatch Database Preview

REOPRO Drug Profile

See Plans and Pricing

« Back to Dashboard

Summary for Tradename: REOPRO
Patents:198
Applicants:1
BLAs:1
Suppliers: see list1
Recent Clinical Trials: See clinical trials for REOPRO
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for REOPRO
Recent Clinical Trials for REOPRO

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Janssen Services, LLCPhase 2
St. Louis UniversityPhase 2
SOS Attaque CérébralePhase 4

See all REOPRO clinical trials

Recent Litigation for REOPRO

Identify key patents and potential future biosimilar entrants

PTAB Litigation
PetitionerDate
Instrumentation Laboratory Company2019-04-24
Instrumentation Laboratory Company2019-02-21
Instrumentation Laboratory Company2017-11-30

See all REOPRO litigation

Patent Text Search: US Patents for REOPRO

These patents were identified by searching patent claims
Glossary
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Centocor Inc REOPRO abciximab INJECTABLE; INJECTION 103575 001 1994-12-22   Start Trial HemoSonics LLC (Charlottesville, VA) 2031-02-15 RX search
Centocor Inc REOPRO abciximab INJECTABLE; INJECTION 103575 001 1994-12-22   Start Trial INSPIREMD, LTD. (IL) 2025-05-24 RX search
Centocor Inc REOPRO abciximab INJECTABLE; INJECTION 103575 001 1994-12-22   Start Trial LOCAL PHARMA, INC. (Las Vegas, NV) 2028-01-09 RX search
Centocor Inc REOPRO abciximab INJECTABLE; INJECTION 103575 001 1994-12-22   Start Trial INSPIRE M.D. LTD (Tel Aviv, IL) 2025-05-24 RX search
Centocor Inc REOPRO abciximab INJECTABLE; INJECTION 103575 001 1994-12-22   Start Trial ALDERBIO HOLDINGS LLC (Las Vegas, NV) 2028-11-25 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Harvard Business School
Colorcon
AstraZeneca
McKinsey
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
Copyright 2002-2019 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2019 - 2020
 NCE-1 Patent Challenge Dates 2019 - 2020
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2019, www.DrugPatentWatch.com.

Links

Follow DrugPatentWatch:

DrugPatentWatch reviews